Navigation Links
Wynonna Judd and alli Host Private Concert in Nashville
Date:3/12/2009

Weight Loss Partners Offer Consumers Chance to Win Tickets to Private Concert through Online Sweepstakes

PARSIPPANY, N.J., March 12 /PRNewswire/ -- alli announced today a sweepstakes program offering consumers the opportunity to attend a private Wynonna Judd concert in Nashville this summer. Slated to take place on July 11th at the Country Music Hall of Fame, the alli-sponsored event will showcase Wynonna Judd, the brand's spokesperson, in an intimate setting while she performs tracks off her recently released album, Sing. Judd will also perform other fan favorites throughout the 90-minute private event.

Beginning March 1st consumers are invited to join the sweepstakes. Entries, which will be collected through www.mystorymyalli.com and/or U.S. mail, will be accepted until May 15th.

alli will award 50 grand prize winners with a two-day/one-night trip for two to attend the private concert in Nashville. Grand prize winners will also receive hotel accommodations, transportation to and from the performance, round-trip airfare, and $250 spending money - a total prize valued at more than $2500.

The alli starter packs and 170-count refill kits are available for purchase at retailers nationwide, including Wal-Mart, Walgreens, Costco, CVS, Target and Kroger.

Complete rules of the sweepstakes may be found at www.mystorymyalli.com

About alli

alli is the only FDA-approved weight-loss product available to overweight adults, 18 years or older, without a prescription. It combines a clinically-proven product with a comprehensive individualized action plan. The alli program encourages gradual weight loss, known by experts as the best way to lose weight. alli (60 mg orlistat capsules) is safe and effective when used as directed.

The alli plan was developed by nutritional and weight management experts who understand the struggle to lose weight. The alli program, which includes a healthy, balanced diet, regular physical activity and alli capsules available in 60-capsule and 90-capsule educational starter packs, works by blocking about 25 percent of fat in the foods eaten to reduce the amount of fat and calories absorbed.

www.myalli.com

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as many medicine cabinet staples, including Abreva(R), Aquafresh(R), Sensodyne(R), Tums(R) and Breathe Right(R).

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline/alli
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wynonna Judd and alli(R) Hit The Road for a Healthier America
2. Wynonna Judd Reveals Her alli(R), Her Story for Finding a Healthier Lifestyle
3. Survey: Few physicians support private banking of umbilical cord blood
4. New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening
5. Medibank Private and HSA Join to Create Better Health Solutions
6. VVA Introduces Collaboration Between Veterans and Private Sector to Address Healthcare Needs for Vets
7. Healthcare Liaison Graduates Nations First Credentialed Private Healthcare Advocates - Graduates are Pioneers in Emerging Profession
8. Consumer Watchdog to U.S. Senate: Dont Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone
9. Vietnam Veterans of America Introduces First Collaboration Between Veterans and Private Sector to Address Healthcare Needs for Vets
10. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
11. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... AvePoint , ... North American office location in Richmond, Virginia, located at the Riverfront Plaza, 901 East ... by Lieutenant Governor of Virginia Ralph S. Northam and Mayor of Richmond Levar M. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual ... the Diabetes Risk Test to find out if they are at risk for developing ... light up the evening sky by programming the LAX pylons the color red. Downtown’s ...
(Date:3/28/2017)... CARTERSVILLE, Georgia (PRWEB) , ... March 28, 2017 ... ... analyst to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, ... been a leader in the real estate valuation industry for more than 40 ...
(Date:3/28/2017)... ... , ... The Thyroid Secret is a specialized 9-part documentary ... was recently launched on March 1, and Dr. Wentz discussed varied benefits and ... Izabella Wentz is a licensed pharmacist and a foremost thyroid specialist. After being ...
(Date:3/28/2017)... ... March 28, 2017 , ... Medforce Technologies, Inc., ... to announce it has joined the National Association for Home Care and Hospice ... ill, disabled, and dying Americans of all ages and the caregiver who provide ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ("Medicure") ... financial results for the year ended December 31, ... 2017. The results are being released later than ... statements will include the operations and balances of ... 2016.  This release and filing date meets TSX ...
(Date:3/28/2017)... March 28, 2017 The global emerging cancer ... of 13.45% from 2016 to 2023 and reach a ... Cancer is a chronic disease and is affecting ... cancer diagnostics market. This report is focused on emerging ... market growth is propelled due to factors such as: ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
Breaking Medicine Technology: